Has William Mitchell, MD received payments from drug or device companies?

Yes. Drug and device makers reported $7,838 in general payments to William Mitchell, MD across 256 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean William Mitchell, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about William Mitchell, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

William Mitchell, MD

Ophthalmology · Huntsville, ALNPI 1720037401

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $6,481 of the $7,838 with a category attached, or 82.7%. 24 manufacturers reported payments, led by Alcon at 44.3% of the total. Among ophthalmology clinicians in AL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$7,838in general payments, 2019–2025

Across 256 payments — averaging $30.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Alcon$3K
Carl Zeiss Meditec USA, Inc.$1K
AbbVie$597
Glaukos Corporation$454
Johnson & Johnson Surgical Vision, Inc.$379
Ivantis, Inc$268
plus $1K from 18 others

What the payments were for

Speaking & faculty fees$260%
Food & beverage$6,48183%
Other$1,33117%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Alcon	133	$3,471
Carl Zeiss Meditec USA, Inc.	2	$1,331
AbbVie(2 entities)	21	$597
Glaukos Corporation	14	$454
Johnson & Johnson Surgical Vision, Inc.	19	$379
Ivantis, Inc	5	$268
NEW World Medical,inc.	8	$200
Sun Pharmaceutical Industries Inc.	8	$167
Bausch & Lomb, A Division Of Bausch Health US, LLC	7	$142
Novartis	7	$131
AstraZeneca	4	$118
Bausch & Lomb Americas Inc.	5	$99
Rxsight Inc	4	$94
Mallinckrodt Hospital Products Inc.	3	$75
Sight Sciences, Inc.	3	$62
Oyster Point Pharma, Inc.	3	$54
Ocular Therapeutix, Inc.	2	$44
Thea Pharma Inc.	2	$39
Pfizer	1	$26
Array Biopharma Inc	1	$23
Eyepoint US, Inc.	1	$17
Eyevance Pharmaceuticals LLC	1	$17
Iridex Corporation	1	$17
Amgen	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,838 in reported general payments places this provider in the 90th percentile of 197 ophthalmology providers in Alabama.

See all ophthalmology providers in Alabama →

Medicare billing

Part B allowed, 2024

$637,149

Medicare patients

843

Services billed

3,318

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Prednisolone Acetate	33	$2,099
Latanoprost	23	$471
Ofloxacin	18	$220

Paid to pharmacies, not to this prescriber.

Other ophthalmology in Huntsville

Caroline WatsonHuntsville$292K
Jonathan RamseyHuntsville$8K
Paul FrederickHuntsville$6K
Robert FosterHuntsville$6K
Patricia McCoyHuntsville$5K
Robert StevensHuntsville$5K
Walter HubickeyHuntsville$4K
Bret FisherHomewood$545K
Ronald GrossFairhope$143K
Kristin BainsBirmingham$40K

See the full list for Alabama →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →